PFENEX INC. – Trademark Portfolio
Entity Type: 03
PFENEX INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BONSITY, PELICRM, PELICRM197, PFENEX EXPRESSION TECHNOLOGY, and PELICAN EXPRESSION TECHNOLOGY. The owner is based in SAN DIEGO, CA.
10790 Roselle Street
SAN DIEGO, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
PFENEX INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Legal services; security services for the protection of property and individuals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PFENEX INC. have?
PFENEX INC. has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned.
What trademark classes does PFENEX INC. file in?
PFENEX INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 45 (Legal & Security Services), Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PFENEX INC.'s most well-known trademarks?
PFENEX INC.'s registered trademark portfolio includes well-known marks such as BONSITY, PELICRM, PELICRM197, PFENEX EXPRESSION TECHNOLOGY, and PELICAN EXPRESSION TECHNOLOGY. These are among 6 currently registered trademarks in the portfolio.
What is PFENEX INC.'s trademark registration success rate?
PFENEX INC. has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.